Sleep Breath. 2025 Apr 23;29(2):167. doi: 10.1007/s11325-025-03323-1.
ABSTRACT
PURPOSE: Comorbid insomnia and sleep apnea (COMISA) is a prevalent clinical syndrome. We characterized differences in characteristics and medication use patterns between participants with COMISA and those with sleep apnea alone.
METHODS: Data used came from 2018 Health and Retirement Study, a nationally representative cohort study of U.S. middle-aged and older adults. Participants were asked if “a doctor had ever told them they have a sleep disorder” and which disorder. They also reported frequency of insomnia symptoms (i.e., “falling asleep,” “waking during the night,” “waking too early,”) and how often they “felt rested in the morning.” We tested differences in demographic and clinical characteristics as well as medication use between participants with COMISA vs. those with sleep apnea alone by using logistic regression.
RESULTS: Out of N = 1,776 with sleep apnea, 47% had COMISA. Compared to those with sleep apnea alone, participants with COMISA were more likely to be female (p = 0.032), have lower education (p < 0.001), and report lung disease, stroke, psychiatric problems, and dementia/cognitive impairment (all p’s < 0.001). They reported difficulty in functioning (i.e., activities of daily living), and greater depressive symptomatology (all p’s < 0.001). Finally, they were more likely to report the use of opioids (p = 0.037), stomach (p = 0.028), and sleep medications (p < 0.001).
CONCLUSIONS: Compared to those with sleep apnea alone, COMISA participants had a more medically complex health profile and medication use that may exacerbate sleep apnea (e.g., opioids and sleep medications). Future research should focus on managing COMISA in medically complex patients for improved health outcomes.
PMID:40266384 | DOI:10.1007/s11325-025-03323-1
Recent Comments